What is the official website of Carmot Therapeutics, Inc. ?

The official website of Carmot Therapeutics, Inc. is http://carmot-therapeutics.us/.

What is Carmot Therapeutics, Inc.'s cybersecurity risk score?

Carmot Therapeutics, Inc. has an AI-generated cybersecurity risk score of 794 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Carmot Therapeutics, Inc. experienced?

According to Rankiteo, Carmot Therapeutics, Inc. currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Carmot Therapeutics, Inc. been affected by any supply chain cyber incidents ?

According to Rankiteo, Carmot Therapeutics, Inc. has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Carmot Therapeutics, Inc. have SOC 2 Type 1 certification ?

According to Rankiteo, Carmot Therapeutics, Inc. is not certified under SOC 2 Type 1.

Does Carmot Therapeutics, Inc. have SOC 2 Type 2 certification ?

According to Rankiteo, Carmot Therapeutics, Inc. does not hold a SOC 2 Type 2 certification.

Does Carmot Therapeutics, Inc. comply with GDPR ?

According to Rankiteo, Carmot Therapeutics, Inc. is not listed as GDPR compliant.

Does Carmot Therapeutics, Inc. have PCI DSS certification ?

According to Rankiteo, Carmot Therapeutics, Inc. does not currently maintain PCI DSS compliance.

Does Carmot Therapeutics, Inc. comply with HIPAA ?

According to Rankiteo, Carmot Therapeutics, Inc. is not compliant with HIPAA regulations.

Does Carmot Therapeutics, Inc. have ISO 27001 certification ?

According to Rankiteo,Carmot Therapeutics, Inc. is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Carmot Therapeutics, Inc. operate in ?

Carmot Therapeutics, Inc. operates primarily in the Biotechnology Research industry.

How many employees does Carmot Therapeutics, Inc. have ?

Carmot Therapeutics, Inc. employs approximately 5 people worldwide.

Does Carmot Therapeutics, Inc. own any subsidiaries ?

Carmot Therapeutics, Inc. presently has no subsidiaries across any sectors.

How many LinkedIn followers does Carmot Therapeutics, Inc. have ?

Carmot Therapeutics, Inc.'s official LinkedIn profile has approximately followers.

What is the NAICS classification code for Carmot Therapeutics, Inc. ?

Carmot Therapeutics, Inc. is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Carmot Therapeutics, Inc. have a Crunchbase profile ?

Yes, Carmot Therapeutics, Inc. has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/carmot-therapeutics.

Does Carmot Therapeutics, Inc. have a LinkedIn profile ?

Yes, Carmot Therapeutics, Inc. maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/carmot-therapeutics-inc.

How many cybersecurity incidents has Carmot Therapeutics, Inc. experienced ?

As of June 17, 2026, Rankiteo reports that Carmot Therapeutics, Inc. has not experienced any cybersecurity incidents.

How many peer or competitor companies does Carmot Therapeutics, Inc. have ?

Carmot Therapeutics, Inc. has an estimated 4,705 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

CTI

Boost Score +25 with badge (5 left)

794

/1000

Fair

819

/1000

Good

Carmot Therapeutics, Inc. Vendor Cyber Rating & Cyber Score

carmot-therapeutics.us

cb in

Add Your Compliance Badge

Carmot has been acquired by Roche in early 2024, making the company a member of the Roche Group. Carmot Therapeutics is a clinical-stage biotechnology company that is focused on advancing life-changing therapeutics for people with obesity and diabetes. We are utilizing Chemotype Evolution, a pioneering drug discovery platform, to identify novel incretin receptor signaling targets to develop a broad pipeline of therapeutics that have the potential to produce significant weight loss and improved glycemic control. We have three clinical candidates: CT-388, CT-868 and CT-996.

CTI A.I CyberSecurity Scoring

Scoring History

CTI

Carmot Therapeutics, Inc. CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

CTI Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for CTI

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Carmot Therapeutics, Inc. in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Carmot Therapeutics, Inc. in 2026.

Incident Types CTI vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Carmot Therapeutics, Inc. in 2026.

Incident History - CTI (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Carmot Therapeutics, Inc. Subsidiaries

CTI

Biotechnology Research

Website: http://carmot-therapeutics.us/

Company Size: 11-50 employees

RocheBiotechnology Research

Roche SwedenTillverkning av läkemedel

Roche AustraliaBiotechnology Research

Roche Middle EastBiotechnology Research

Roche Malaysia Penyelidikan Bioteknologi

Roche Diabetes CareMedical Equipment Manufacturing

GenMark DiagnosticsMedical Equipment Manufacturing

Ventana Medical SystemsBiotechnology Research

GenentechBiotechnology Research

Genentech MedicalBiotechnology Research

Roche Diagnostics DanmarkMedical Equipment Manufacturing

中外製薬 / Chugai Pharmaceutical Co., Ltd.Pharmaceutical Manufacturing

Roche Diagnostics Asia PacificBiotechnology Research

Roche Diagnostics AustraliaBiotechnology Research

Roche IndonesiaBioteknologi

Roche VietnamBiotechnology Research

LabLeadersHospitals and Health Care

Roche DanmarkForskning inden for bioteknologi

Roche HungaryBiotechnology Research

Roche Diagnostics NederlandHospitals and Health Care

Roche Diagnostics SwedenHospitals and Health Care

Roche in Belgium & LuxembourgBiotechnology Research

Roche MéxicoPharmaceutical Manufacturing

Roche IsraelPharmaceutical Manufacturing

Roche Hong Kong 羅氏香港Biotechnology Research

Roche Tunisiaتصنيع المستحضرات الصيدلانية

Roche Diagnostics BelgiumBiotechnology Research

Roche Sequencing USABiotechnology Research

Roche Diagnostics FranceFabrication d’équipements médicaux

Roche AfricaBiotechnology Research

Roche ArgentinaFabricación de productos farmacéuticos

Roche DeutschlandBiotechnologieforschung

Roche PerúFabricación de productos farmacéuticos

Healthcare TransformersBiotechnology Research

Roche UruguayFabricación de productos farmacéuticos

Roche in AustriaArzneimittelherstellung

Roche CustomBiotech - North AmericaBiotechnology Research

Roche LATAMPesquisa biotecnológica

Roche FranceRecherche en biotechnologie

Roche Costa RicaInvestigación biotecnológica

Roche BangladeshPharmaceutical Manufacturing

Roche i NorgeSykehus og helsetjenester

Roche Diabetes Care FranceFabrication d’équipements médicaux

Roche Česká republikaBiotechnologie

Roche PolskaProdukcja wyrobów farmaceutycznych

Roche EcuadorFabricación de productos farmacéuticos

Fondation RocheOrganisations à but non lucratif

Roche CanadaBiotechnology

Roche Diagnostics USABiotechnology Research

Roche Diagnostics PakistanBiotechnology Research

Roche ChileFabricación de productos farmacéuticos

Loading…

Carmot Therapeutics, Inc. Similar Companies

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Genentech

gene.com

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Charles River Laboratories

criver.com

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Loading…

NEWS

Carmot Therapeutics, Inc. CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

May 16, 2024 07:00 AM

Roche shares jump on obesity drug results from early-stage trial

Roche shares gained as much as 4.7% on Thursday after an early-stage trial showed that a newly-acquired obesity drug candidate led to...

Read Article

December 04, 2023 08:00 AM

Roche joins race for obesity drugs with $2.7 billion Carmot deal

Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants...

Read Article

December 04, 2023 08:00 AM

Roche enters obesity market with Carmot takeover but drugs may not be available until 2030

Roche is to acquire anti obesity drug developer Carmot Therapeutics, becoming the latest pharma company to enter the global weight-loss...

Read Article

December 03, 2023 08:00 AM

Carmot Therapeutics Enters into Definitive Merger Agreement with Roche

Roche to acquire Carmot for an upfront payment of $2.7 billion and the potential for $400 million in milestone payments – – Carmot will join...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-48777

SUMMARY

FileBrowser Quantum is a free, self-hosted, web-based file manager. Versions prior to 1.3.2-stable, 1.4.0-beta and 1.4.1-beta are vulnerable to Path Traversal through the publicPatchHandler in backend/http/public.go which joins user-controlled fromPath and toPath body fields with the trusted d.share.Path BEFORE the downstream sanitizer runs. Because filepath.Join collapses .. segments during the join, the sanitizer in resourcePatchHandler never sees the traversal and the move/copy/rename operates on a path outside the shared directory. The same root-cause pattern was patched for the bulk DELETE endpoint as CVE-2026-44542 (GHSA-fwj3-42wh-8673), but the PATCH handler with the identical pattern was not updated. A public share link with AllowModify=true is sufficient to exploit this. Anyone holding such a link can move, copy, or rename arbitrary files within the share owner's source root. This issue has been fixed in versions 1.3.3-stable and 1.4.2-beta.

Published

Date2026-06-16

Updated

Date2026-06-16

RISK INFORMATION (Score: )

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-47750

SUMMARY

stable-diffusion.cpp is a pure C/C++ library for running diffusion model (Stable Diffusion, Flux, Wan, Qwen Image, Z-Image, and more) inference. In versions prior to master-584-0a7ae07, the pickle .ckpt parser in src/model.cpp contained a heap buffer overflow vulnerability in the GLOBAL opcode handler. The issue was caused by missing validation when searching for newline-delimited fields. A crafted .ckpt file without the expected newline could cause the parser to use -1 as a copy length, resulting in immediate heap corruption. The attack requires the victim or application to load a .ckpt file from an untrusted source, such as a downloaded model from a model sharing site. The issue has been resolved in version master-584-0a7ae07. If developers are unable to immediately update their applications they can work around this issue by following these instructions: do not load .ckpt checkpoint files from untrusted sources, and prefer trusted model sources and safer formats such as .safetensors where possible.

Published

Date2026-06-16

Updated

Date2026-06-16

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

CVE-2026-47747

SUMMARY

stable-diffusion.cpp is a pure C/C++ library for running diffusion model (Stable Diffusion, Flux, Wan, Qwen Image, Z-Image, and more) inference. In versions prior to master-584-0a7ae07, the pickle .ckpt parser in src/model.cpp contained a heap buffer overflow vulnerability in the BINUNICODE opcode handler. The issue was caused by sign confusion on the opcode length field. A crafted .ckpt file could trigger memcpy with a very large length derived from a negative signed value, causing immediate heap corruption. The issue has been resolved in version master-584-0a7ae07. If developers are unable to immediately update their applications they can work around this issue by only loading .ckpt checkpoint files from trusted sources and preferring trusted model sources and safer formats such as .safetensors where possible.

Published

Date2026-06-16

Updated

Date2026-06-16

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

CVE-2026-46448

SUMMARY

In OpenStack Nova before 33.0.2, the server create API does not strip certain hint data. The resulting instance has no Placement allocation.

Published

Date2026-06-16

Updated

Date2026-06-16

RISK INFORMATION (Score: 5.4)

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:L

Impact Score

2.5

Exploitability

2.8

REFERENCES

CVE-2026-22313

SUMMARY

The device has a webserver that exposes a REST API authenticated with a token on the management network. By exploiting an OS command injection vulnerability an authenticated attacker can send arbitrary commands to the device that are executed with administrative permissions by the underlying operating system.

Published

Date2026-06-16

Updated

Date2026-06-16

RISK INFORMATION (Score: 9.1)

cvss3

Base Score: 9.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H

Impact Score

Exploitability

2.3

REFERENCES

https://www.cvcn.gov.it/cvcn/cve/CVE-2026-22313

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…